iNtRON Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
iNtRON Biotechnology has a total shareholder equity of ₩96.7B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩98.6B and ₩1.9B respectively.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | n/a |
| Cash | ₩57.18b |
| Equity | ₩96.73b |
| Total liabilities | ₩1.88b |
| Total assets | ₩98.61b |
Recent financial health updates
We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt
May 03
iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet
Jan 05Recent updates
We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt
May 03We Believe iNtRON Biotechnology's (KOSDAQ:048530) Earnings Are A Poor Guide For Its Profitability
Mar 24Does iNtRON Biotechnology's (KOSDAQ:048530) Share Price Gain of 81% Match Its Business Performance?
Feb 28iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 31
iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet
Jan 05What iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) 26% Share Price Gain Is Not Telling You
Dec 10iNtRON Biotechnology (KOSDAQ:048530) Share Prices Have Dropped 49% In The Last Five Years
Nov 26Financial Position Analysis
Short Term Liabilities: A048530's short term assets (₩61.0B) exceed its short term liabilities (₩786.0M).
Long Term Liabilities: A048530's short term assets (₩61.0B) exceed its long term liabilities (₩1.1B).
Debt to Equity History and Analysis
Debt Level: A048530 is debt free.
Reducing Debt: A048530 has no debt compared to 5 years ago when its debt to equity ratio was 10.6%.
Debt Coverage: A048530 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: A048530 has no debt, therefore coverage of interest payments is not a concern.